Business News
HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US, Business News

Business new tamfitronics

WILMINGTON, Del./PRNewswire/ — Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquisition, advised by Evercore as financial advisor, marks HiRO’s third CRO acquisition since its establishment in 2020.

Following the acquisitions of ANZ-based PharmaSols in 2021 and US-based Courante Oncology last year, HiRO’s global expansion continues with the integration of DeltaMed Solutions. With its established footprint in the US, IrelandMainland China, Taiwan, Australia, New Zealand, Japan, South Korea, Malaysiaand the PhilippinesHiRO solidifies its position as a comprehensive provider of end-to-end clinical research solutions on a global scale.

DeltaMed Solutions, headquartered in New Jerseyboasts a team of highly skilled industry professionals with 15-30 years of expertise in serving large to mid-sized pharmaceutical and biotechs. The leadership team also brings a wealth of experience in FDA and EMEA submissions. DeltaMed Solutions is widely recognized for its extensive experience and flexible service models in data management, biostatistics, programming, RWE solutions, PK/PD analysis, regulatory and medical affairs. The company has earned recognition from clients and partners for its outstanding track record of excellence and service quality.

The full integration of DeltaMed Solutions into HiRO’s operations will foster a powerful alliance, leveraging the expertise of both companies in key therapeutic areas and service offerings. This broadens HiRO’s network of clients and partners, and enhances its ability to deliver capital-efficient, expedited, and customized clinical trial solutions, addressing the unmet R&D needs of pharmaceutical and biotech companies worldwide.

Dr. Karen Chu, Founder and CEO of HiRO, expressed her confidence in the acquisition, stating, “We are delighted to extend a warm welcome to DeltaMed Solutions. This acquisition aligns seamlessly with HiRO’s growth strategy, enhancing our capability to continue delivering exceptional services that exceed industry standards. By combining our resources and expertise, we are strongly positioned to become our clients’ trusted partner in advancing patient treatments and making a lasting impact on the healthcare landscape. This collaboration leverages our collective strengths, ensuring optimal efficiency and effectiveness in conducting clinical trials across a wide range of therapeutic areas in the US, Asia-Pacificand beyond. This sets us apart as a pioneering force in the highly competitive CRO industry.”

Dr. Sam Liang, President of DeltaMed Solutions, added, “We are thrilled to become an integral part of HiRO and contribute to their continued success. This opportunity allows us to harness our scientific expertise and well-established presence in the US. Working together, we will offer an enriched, globally integrated suite of services to our clients, driven by our shared dedication to quality, innovation, and patient-centric research. This collaboration will streamline processes and accelerate the development of groundbreaking treatments.”

With this strategic acquisition, HiRO and DeltaMed Solutions join forces to provide an unparalleled range of services, delivering bespoke and efficient clinical trial solutions that effectively navigate market-specific complexities globally. Their shared vision and commitment to excellence in clinical research uniquely position them as key contributors to advancements in healthcare and pharmaceutical innovation.

About Harvest Integrated Research Organization (HiRO)

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO). With global operations and integrated capabilities, HiRO provides a full range of cross-border solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design, regulatory affairs, pharmacovigilance, statistics, data management, end-to-end project management, and clinical and medical monitoring services.

As an emerging global CRO, HiRO strives to become a market-leading, integrated global clinical research organization that works collaboratively with biotech and pharmaceutical companies to bring new products from the laboratory to the market, providing more effective solutions for patients worldwide. For more information on HiRO, please visit www.harvestiro.com.

About DeltaMed Solutions

DeltaMed Solutions is a global life sciences CRO. The company excels in building strategic partnerships with pharmaceutical companies, biotechnology firms, and CROs. By fostering these collaborations, DeltaMed Solutions remains at the forefront of innovation, driving advancements in clinical research and drug development.

With a focus on flexibility, DeltaMed Solutions offers a range of service models tailored to meet diverse needs, all backed by a team of experienced professionals. Their commitment to excellence ensures the delivery of exceptional quality products, including CSRs, regulatory submissions, and publications. DeltaMed Solutions leverages their extensive expertise and experience to accelerate the market entry of innovative therapies, resulting in significant reductions in time and cost. For more information on DeltaMed Solutions, please visit www.deltamedsolutions.com.

For media inquiries, please contact:
[email protected]

Business News
SUSE Acquires StackState to Provide Full Stack, Cloud Native Observability, Business News

Business new tamfitronics

End-to-end observability platform enhances Rancher Prime, enables customers to manage complexity at scale with confidence

BERLIN, June 18, 2024 /PRNewswire/ — (SUSECON 2024) —SUSE®, a global leader in innovative, open and secure enterprise-grade solutions, today announced that it has acquired the full stack observability platform StackState. StackState’s technology gives IT teams the fastest path to identifying and remedying issues within their containerized cloud-based environments through a single observability platform. With StackState, SUSE will accelerate cloud native observability for the enterprise by integrating the platform into Rancher Primeits premium container management service.

SUSE CEO Dirk-Peter van Leeuwen said, “As IT environments become more complex, our Rancher Prime customers need end-to-end observability of their entire stack. StackState’s comprehensive infrastructure and application monitoring capabilities and technical talent are the perfect complement to Rancher Prime and sets up SUSE’s container management solutions to best serve our customers on their modernization journey. I know our customers will value it greatly as we roll it out.”

With the rapid adoption of cloud and containers, traditional monitoring approaches are becoming obsolete, driving the growth and need for cloud native observability. StackState’s end-to-end observability and application monitoring will be directly incorporated into SUSE’s Rancher Prime, the industry’s most widely adopted enterprise container management platform. This helps customers proactively safeguard their end-user’s experience, foster cross-team collaboration and innovation, and bring all of their cloud native applications together in a single view, from data center to the Edge to the cloud. To foster widespread adoption of cloud native observability, SUSE also announced its intention to open source StackState in the future.

As systems and devices continue to come online at an increasing rate, there will be an equally increasing demand for AI data analytics. StackState’s technology allows users to correlate events over a period of time to help identify root causes in complex distributed systems and suggests remedial actions. StackState’s capabilities will further enhance SUSE’s portfolio, and drive overall innovation, efficiency, and value for customers. This acquisition also opens up broad opportunities for future capabilities like Cost Management, smart issue remediation, environment optimization and Industrial IoT observability.

Andreas PrinsCEO of StackState said, “I am so proud of everything the team at StackState has built since we launched. We offer unparalleled observability to customers running mission critical workloads in complex environments. SUSE’s Rancher Prime is a great fit for our technology and our team – and I’m looking forward to seeing what we have built reach its full potential.”

SUSE CEO DP van Leewen has blogged about the deal here.

About SUSE
SUSE is a global leader in innovative, reliable and secure enterprise open source solutions, including SUSE Linux Enterprise, Rancher and NeuVector. More than 60% of the Fortune 500 rely on SUSE to power their mission-critical workloads, enabling them to innovate everywhere – from the data center to the cloud, to the edge and beyond. SUSE puts the “open” back in open source, collaborating with partners and communities to give customers the agility to tackle innovation challenges today and the freedom to evolve their strategy and solutions tomorrow. For more information, visit www.suse.com.

About StackState

https://www.stackstate.com/solutions/kubernetes-troubleshooting/
https://www.stackstate.com/

Media contact: [email protected]

Business News
Clarivate Acquires International QMS, Inc., Expanding Existence Sciences & Healthcare Segment into New Markets, Industry Data

Business new tamfitronics

Acquisition helps severe client workflow and reporting wants with proprietary SaaS platform, automating regulatory describe authoring and compliance for the duration of manufacturing operations, supply chain and quality management

LONDON, April 23, 2024 /PRNewswire/ — Clarivate Plc (NYSE:CLVT) a number one global provider of transformative intelligence, lately announced that it has bought International QMS, Inc., is named International Q, a provider of cloud-basically based alternatives that enable existence sciences purchasers to automate regulatory reporting and compliance management. Financial phrases of the transaction were now not disclosed.

International Q helps leading pharma, medtech and biotech companies by providing comprehensive entry to linked and standardized workflow-involving data via its SaaS platform, Optiqs360 Digital™. The platform involves MediGPT – WorkCenter™ and MediGPT – IntelliWriter™, alternatives that supply purchasers with interconnected data visibility and broken-down user interfaces, for the duration of interior and exterior sources of describe. The instruments give a enhance to the advanced workflows and reporting wants of clinical, regulatory, product lifecycle and quality management consultants, greatly streamlining annual product experiences, scientific instrument experiences and provide chain insights.

Clarivate brings together linked data, deep abilities and intelligence alternatives to empower existence sciences and healthcare companies to ship protected, effective and commercially successful therapies to patients faster. The acquisition of International Q bolsters a sturdy integrated platform of existence science intelligence alternatives from pre-clinical and clinical offerings and further expands Clarivate capabilities in manufacturing and provide chain management to encompass regulatory describe authoring and compliance management. The workflow and reporting capabilities of International Q complement the Clarivate Cortellis Generics Intelligence resolution for Packed with life Pharmaceutical Ingredient (API) monitoring. The addition of these cloud-basically based alternatives will relief to embed Clarivate into severe client workflows and enable the expansion of Clarivate services into unusual markets.

Henry LevyPresident, Existence Sciences & Healthcare, Clarivate, acknowledged: “Clarivate continues to search out, get and mix subsequent-generation workflow automation machine that streamlines and digitizes manual workflows. The acquisition of International Q builds on our approach to ship alternatives that empower our purchasers to advance therapies that give a enhance to patient lives. The combined abilities, data and applied sciences of Clarivate and International Q will benefit to address the customer need for linked data to present a enhance to advanced analyses and evidence-basically based decisions within the existence sciences.”

Mitch HayesFounder & Chief Govt Officer, International QMS, Inc., acknowledged: “The acquisition of International Q by Clarivate reinforces our joint missions to benefit global organizations salvage profound insights and efficiencies in bringing existence-saving therapies to their patients worldwide. The combined trade will extra the imaginative and prescient of striking contextually conscious intelligence straight into our prospects’ workflows and facilitating their day-to-day responsibilities in ideas never ahead of probably.”

Existence sciences consultants in price for unusual product style, manufacturing and regulatory compliance are taking a look to connect the dots for the duration of extra than one data facets to velocity up their treatment and prevention efforts and problem better patient health outcomes. Harmonized and linked data sources can address the industry need for allege authoring automation spanning extra than one programs and workflows. The acquisition of International Q lets in Clarivate to seamlessly tap into the digital thread market, considering proprietary data and insights gleaned from Clarivate alternatives to frictionlessly be integrated into customer workflows.

Following the successful acquisition and integration of companies, alongside side Decision Sources Team (DRG), Bioinfogate, Patient Connect, Dialog (phase of ProQuest) and IP from MotionHall, the acquisition of International Q extra demonstrates the persevering with investment by Clarivate in excessive-value data, analytics and progressive technology paired with deep arena topic and technical abilities internal its Existence Sciences and Healthcare segment.

As a trusted companion in shaping the style forward for healthcare, Clarivate proactively addresses industry demands via intelligence platforms that connect data and spend AI and progressed analytics to revolutionize patient engagement, overcome entry boundaries and fulfill unmet wants. The complementary alternatives of Clarivate and International Q will better space the firm in a market that favors progressive tech-enabled suppliers with live-to-live capabilities and absorbing market-leading data gadgets.

Ahead-Taking a look Statements
This communication incorporates “forward-taking a look statements” as defined within the Non-public Securities Litigation Reform Act of 1995. These statements, which impart management’s most up-to-date views concerning future trade, events, trends, contingencies, financial efficiency, or financial situation, seem at assorted areas in this communication and could maybe well spend words be pleased “diagram,” “sit up for,” “inform,” “imagine,” “proceed,” “could maybe well,” “estimate,” “ask,” “forecast,” “future,” “operate,” “intend,” “seemingly,” “could maybe well,” “could maybe well,” “conception,” “doable,” “predict,” “mission,” “scrutinize,” “sight,” “could maybe well mute,” “approach,” “are attempting,” “target,” “will,” and “would” and identical expressions, and variations or negatives of these words.  Ahead-taking a look statements are neither historical facts nor assurances of future efficiency. Instead, they are basically based only on management’s most up-to-date beliefs, expectations, and assumptions concerning the style forward for our trade, future plans and ideas, projections, anticipated events and trends, the economy, and various future prerequisites. Attributable to forward-taking a look statements dispute to the future, they are subtle to predict and a form of which could maybe well be exterior of our control. Crucial factors that could maybe well put off our trusty results and financial situation to fluctuate materially from these indicated within the forward-taking a look statements encompass these factors talked about below the caption “Chance Components” in our most most up-to-date annual describe on Construct 10-Okay, on the side of our various filings with the U.S. Securities and Alternate Commission (“SEC”). On the opposite hand, these factors could maybe well mute now not be regarded as to be a total statement of all doable dangers and uncertainties. Further dangers and uncertainties now not known to us or that we currently mediate immaterial could maybe well also impair our trade operations. Ahead-taking a look statements are basically based only on info currently on hand to our management and focus on only as of the date of this communication. We attain now not inform any responsibility to publicly provide revisions or updates to any forward-taking a look statements, whether as a results of most up-to-date info, future trends or otherwise, excluding as otherwise required by securities and various relevant authorized guidelines. Please consult our public filings with the SEC or on our web region atwww.clarivate.com.

About Clarivate
Clarivate™ is a number one global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow alternatives and educated services within the areas of Academia & Executive, Mental Property and Existence Sciences & Healthcare. For further info, please focus on over with www.clarivate.com

About International QMS, Inc.
International QMS, Inc., is named International Q, is a provider of a cloud-basically based lustrous workflow platform that affords our prospects an interconnected workspace that lets in them to derive a composite behold of all their product data (“digital threads”), alongside side interior R&D, post market, regulatory, manufacturing, and others, to boot to exterior feeds and trusty-world data.

Media Contact:
Catherine DanielDirector, Exterior Communications
[email protected]

Investor Relations Contact
Mark DonohueHead of Investor Relations 
[email protected]